{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:54:45Z","timestamp":1771610085171,"version":"3.50.1"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The pandemic respiratory illness SARS-CoV-2 has increasingly been shown to be a systemic disease that can also have profound impacts on the cardiovascular system. Although associated cardiopulmonary sequelae can persist after infection, the link between viral infection and these complications remains unclear. There is now a recognized link between endothelial cell dysfunction and thrombosis. Its role in stimulating platelet activation and thrombotic inflammation has been widely reported. However, the procoagulant role of microparticles (MPs) in COVID-19 seems to have been neglected. As membrane vesicles released after cell injury or apoptosis, MPs exert procoagulant activity mainly by exposing phosphatidylserine (PS) on their lipid membranes. It can provide a catalytic surface for the assembly of the prothrombinase complex. Therefore, inhibiting PS externalization is a potential therapeutic strategy. In this paper, we describe the pathophysiological mechanism by which SARS-CoV-2 induces lung and heart complications through injury of endothelial cells, emphasizing the procoagulant effect of MPs and PS, and demonstrate the importance of early antithrombotic therapy. In addition, we will detail the mechanisms underlying hypoxia, another serious pulmonary complication related to SARS-CoV-2-induced endothelial cells injury and discuss the use of oxygen therapy. In the case of SARS-CoV-2 infection, virus invades endothelial cells through direct infection, hypoxia, imbalance of the RAAS, and cytokine storm. These factors cause endothelial cells to release MPs, form MPs storm, and eventually lead to thrombosis. This, in turn, accelerates hypoxia and cytokine storms, forming a positive feedback loop. Given the important role of thrombosis in the disease, early antithrombotic therapy is an important tool for COVID-19. It may maintain normal blood circulation, accelerating the clearance of viruses, waning the formation of MPs storm, and avoiding disease progression.<\/jats:p>","DOI":"10.3389\/fcvm.2022.957006","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T06:43:38Z","timestamp":1659681818000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment"],"prefix":"10.3389","volume":"9","author":[{"given":"Langjiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijiao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie A.","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"606318","DOI":"10.3389\/fcvm.2021.606318","article-title":"Right ventricular damage in COVID-19: association between myocardial injury and COVID-19","volume":"8","author":"Lan","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e230421189016","DOI":"10.2174\/1573403X16999201210200614","article-title":"COVID-19 severity: lung-heart interplay","volume":"17","author":"Puri","year":"2021","journal-title":"Curr Cardiol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-022-00907-1","article-title":"The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication","volume":"7","author":"Ning","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"713560","DOI":"10.3389\/fcvm.2021.713560","article-title":"COVID-19 and heart failure: from epidemiology during the pandemic to myocardial injury, myocarditis, and heart failure sequelae","volume":"8","author":"Italia","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.120.050754","article-title":"COVID-19-associated nonocclusive fibrin microthrombi in the heart","volume":"143","author":"Bois","year":"2021","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1007\/s12035-021-02457-z","article-title":"COVID-19 infection and circulating microparticles-reviewing evidence as microthrombogenic risk factor for cerebral small vessel disease","volume":"58","author":"Che Mohd Nassir","year":"2021","journal-title":"Mol Neurobiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e12173","DOI":"10.1002\/jev2.12173","article-title":"Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients","volume":"10","author":"Rausch","year":"2021","journal-title":"J Extracell Vesicles."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/bjh.18019","article-title":"Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner","volume":"196","author":"Garnier","year":"2022","journal-title":"Br J Haematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"H1181","DOI":"10.1152\/ajpheart.00579.2020","article-title":"Extracellular vesicles: new players in regulating vascular barrier function","volume":"319","author":"Chatterjee","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood-2016-09-739334","article-title":"Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia","volume":"129","author":"Cao","year":"2017","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1160\/TH15-09-0710","article-title":"Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease","volume":"115","author":"He","year":"2016","journal-title":"Thromb Haemost."},{"key":"B16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S2213-2600(20)30407-0","article-title":"Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19","volume":"9","author":"Dhawan","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"n311","DOI":"10.1136\/bmj.n311","article-title":"Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study","volume":"372","author":"Rentsch","year":"2021","journal-title":"BMJ."},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12967-020-02324-w","article-title":"CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.pulmoe.2020.10.017","article-title":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)","volume":"27","author":"Hashemian","year":"2021","journal-title":"Pulmonology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA","article-title":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S1473-3099(21)00211-5","article-title":"Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study","volume":"21","author":"Lund","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2001217","DOI":"10.1183\/13993003.01217-2020","article-title":"Abnormal pulmonary function in COVID-19 patients at time of hospital discharge","volume":"55","author":"Mo","year":"2020","journal-title":"Eur Respir J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2001754","DOI":"10.1183\/13993003.01754-2020","article-title":"Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection","volume":"56","author":"Frija-Masson","year":"2020","journal-title":"Eur Respir J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"101004","DOI":"10.1016\/j.cpcardiol.2021.101004","article-title":"Severe pulmonary hypertension: an important sequel after severe post-acute COVID-19 pneumonia","volume":"47","author":"Cueto-Robledo","year":"2022","journal-title":"Curr Probl Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/infdis\/jiab075","article-title":"Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection","volume":"223","author":"Tarhini","year":"2021","journal-title":"J Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (pasc): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12805","DOI":"10.1111\/anec.12805","article-title":"Electrocardiograhic characteristics in patients with coronavirus infection: a single-center observational study","volume":"25","author":"Li","year":"2020","journal-title":"Ann Noninvasive Electrocardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.120.047525","article-title":"ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes","volume":"141","author":"Stefanini","year":"2020","journal-title":"Circulation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMc2009020","article-title":"ST-segment elevation in patients with COVID-19-a case series","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"B36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.120.048476","article-title":"Association of hydroxychloroquine with qtc interval in patients with COVID-19","volume":"142","author":"Mazzanti","year":"2020","journal-title":"Circulation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.11604\/pamj.2021.39.173.27802","article-title":"Cardiac manifestations of the coronavirus disease-19: a review of pathogenesis, clinical manifestations, diagnosis, and treatment","volume":"39","author":"Khalid","year":"2021","journal-title":"Pan Afr Med J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","article-title":"Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction","volume":"142","author":"Modin","year":"2020","journal-title":"Circulation."},{"key":"B39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10741-020-10037-x","article-title":"Mechanisms of COVID-19-induced heart failure: a short review","volume":"26","author":"Adeghate","year":"2021","journal-title":"Heart Fail Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","article-title":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management","volume":"17","author":"Siripanthong","year":"2020","journal-title":"Heart Rhythm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e007485","DOI":"10.1161\/CIRCHEARTFAILURE.120.007485","article-title":"Cardiogenic shock and hyperinflammatory syndrome in young males with COVID-19","volume":"13","author":"Chau","year":"2020","journal-title":"Circ Heart Fail."},{"key":"B42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ehf2.13186","article-title":"COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture","volume":"8","author":"Tsch\u00f6pe","year":"2021","journal-title":"ESC Heart Fail."},{"key":"B43","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s11239-020-02332-z","article-title":"Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients","volume":"51","author":"Fan","year":"2021","journal-title":"J Thromb Thrombolysis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"n693","DOI":"10.1136\/bmj.n693","article-title":"Post- COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study","volume":"372","author":"Ayoubkhani","year":"2021","journal-title":"BMJ."},{"key":"B45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jchf.2021.10.002","article-title":"Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease","volume":"9","author":"Mancini","year":"2021","journal-title":"JACC Heart Fail."},{"key":"B46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/biology10060469","article-title":"Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2","volume":"10","author":"Tudoran","year":"2021","journal-title":"Biology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3390\/jcm10112507","article-title":"A multidisciplinary approach to evaluate the presence of hepatic and cardiac abnormalities in patients with post-acute COVID-19 syndrome-a pilot study","volume":"10","author":"Bende","year":"2021","journal-title":"J Clin Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2003481","DOI":"10.1183\/13993003.03481-2020","article-title":"Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial","volume":"57","author":"Sonnweber","year":"2021","journal-title":"Eur Respir J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"110412","DOI":"10.1016\/j.mehy.2020.110412","article-title":"Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: a physio-pathological theory","volume":"146","author":"Carcaterra","year":"2021","journal-title":"Med Hypotheses."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jacc.2020.06.068","article-title":"Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week","volume":"76","author":"Sandoval","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/cvr\/cvaa140","article-title":"COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction","volume":"116","author":"Bermejo-Martin","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.120.052824","article-title":"Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells","volume":"143","author":"McCracken","year":"2021","journal-title":"Circulation."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jacbts.2020.09.010","article-title":"Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG\/CD147) Increases with age in endothelial cells","volume":"5","author":"Ahmetaj-Shala","year":"2020","journal-title":"JACC Basic Transl Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA","article-title":"SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.7150\/thno.61810","article-title":"Endothelial cell infection and dysfunction, immune activation in severe COVID-19","volume":"11","author":"Qin","year":"2021","journal-title":"Theranostics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41422-020-00412-6","article-title":"Single-cell transcriptomic atlas of primate cardiopulmonary aging","volume":"31","author":"Ma","year":"2021","journal-title":"Cell Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/joim.13144","article-title":"Cytokine storm syndrome in coronavirus disease 2019: a narrative review","volume":"289","author":"Gao","year":"2021","journal-title":"J Intern Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00134-020-06059-6","article-title":"Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation","volume":"46","author":"Leisman","year":"2020","journal-title":"Intensive Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.26355\/eurrev_202112_27650","article-title":"Scanning electron microscopy of lung disease due to COVID-19 - a case report and a review of the literature","volume":"25","author":"Congiu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1016\/j.jacc.2020.04.028","article-title":"Clinical implications of SARS-CoV-2 interaction with renin angiotensin system: JACC review topic of the week","volume":"75","author":"Brojakowska","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect."},{"key":"B70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-021-00690-5","article-title":"The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction","volume":"6","author":"Xu","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1002\/ctm2.268","article-title":"Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes","volume":"11","author":"Fern\u00e1ndez-P\u00e9rez","year":"2021","journal-title":"Clin Transl Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","article-title":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?","volume":"56","author":"Huertas","year":"2020","journal-title":"Eur Respir J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1152\/physrev.00035.2020","article-title":"Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets","volume":"101","author":"Sriram","year":"2021","journal-title":"Physiol Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1152\/physrev.00020.2015","article-title":"Getting to the Outer Leaflet: physiology of phosphatidylserine exposure at the plasma membrane","volume":"96","author":"Bevers","year":"2016","journal-title":"Physiol Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbalip.2006.03.006","article-title":"Phosphatidic acid- and phosphatidylserine-binding proteins","volume":"1761","author":"Stace","year":"2006","journal-title":"Biochim Biophys Acta."},{"key":"B77","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.plipres.2005.05.001","article-title":"Metabolism and functions of phosphatidylserine","volume":"44","author":"Vance","year":"2005","journal-title":"Prog Lipid Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/s0163-7827(03)00025-0","article-title":"Exposure of platelet membrane phosphatidylserine regulates blood coagulation","volume":"42","author":"Lentz","year":"2003","journal-title":"Prog Lipid Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1182\/blood-2002-07-1951","article-title":"Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites","volume":"101","author":"Shi","year":"2003","journal-title":"Blood."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1182\/blood-2011-06-362186","article-title":"Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells","volume":"119","author":"Xie","year":"2012","journal-title":"Blood."},{"key":"B81","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1160\/TH13-09-0802","article-title":"Synergies of phosphatidylserine and protein disulfide isomeRAASe in tissue factor activation","volume":"111","author":"Langer","year":"2014","journal-title":"Thromb Haemost."},{"key":"B82","doi-asserted-by":"publisher","first-page":"117232","DOI":"10.1016\/j.carbpol.2020.117232","article-title":"Comprehensive landscape of heparin therapy for COVID-19","volume":"254","author":"Shi","year":"2021","journal-title":"Carbohydr Polym."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1055\/s-0040-1721319","article-title":"Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin","volume":"120","author":"Mycroft-West","year":"2020","journal-title":"Thromb Haemost."},{"key":"B84","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ajh.26102","article-title":"Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis","volume":"96","author":"Meizlish","year":"2021","journal-title":"Am J Hematol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat Rev Drug Discov."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1055\/s-0040-1715798","article-title":"Guidance for the Management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European Independent Foundation in Angiology\/Vascular Medicine","volume":"120","author":"Gerotziafas","year":"2020","journal-title":"Thromb Haemost."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/jth.14828","article-title":"Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series","volume":"18","author":"Wang","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B88","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","author":"REMAP-CAP","year":"2021","journal-title":"N Engl J Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.2022.2910","article-title":"Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"327","author":"Bradbury","year":"2022","journal-title":"JAMA."},{"key":"B90","doi-asserted-by":"publisher","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with COVID-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ."},{"key":"B91","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/0268355520975595","article-title":"The effectiveness of early anticoagulant treatment in COVID-19 patients","volume":"36","author":"Arslan","year":"2021","journal-title":"Phlebology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1055\/a-1414-5216","article-title":"Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial","volume":"121","author":"Gonzalez-Ochoa","year":"2021","journal-title":"Thromb Haemost."},{"key":"B93","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/d41586-021-03495-2","article-title":"Do vaccines protect against long COVID? What the data say","volume":"599","author":"Ledford","year":"2021","journal-title":"Nature."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2021.20714","article-title":"Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial","volume":"326","author":"Ospina-Tasc\u00f3n","year":"2021","journal-title":"JAMA."},{"key":"B96","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1152066","article-title":"Membrane phosphatidylserine regulates surface charge and protein localization","volume":"319","author":"Yeung","year":"2008","journal-title":"Science."},{"key":"B97","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","article-title":"Small-molecule inhibitors of the coronavirus spike: ACE2 protein-protein interaction as blockers of viral attachment and entry for SARS-CoV-2","volume":"7","author":"Bojadzic","year":"2021","journal-title":"ACS Infect Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e0097021","DOI":"10.1128\/mBio.00970-21","article-title":"The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19","volume":"12","author":"Li","year":"2021","journal-title":"mBio."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436.","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Recovery Collaborative","year":"2021","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.957006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T06:43:44Z","timestamp":1659681824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.957006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":101,"alternative-id":["10.3389\/fcvm.2022.957006"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.957006","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"article-number":"957006"}}